These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24604104)

  • 21. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
    Thiruchelvam D; Charach A; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children.
    Bauermeister JJ; Canino G; Bravo M; Ramírez R; Jensen PS; Chavez L; Martínez-Taboas A; Ribera J; Alegría M; García P
    J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):851-5. PubMed ID: 12819445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional study.
    Biederman J; Fried R; Petty CR; Henin A; Wozniak J; Corkum L; Claudat K; Faraone SV
    J Nerv Ment Dis; 2012 Jan; 200(1):69-75. PubMed ID: 22210365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey.
    Lensing MB; Zeiner P; Sandvik L; Opjordsmoen S
    J Clin Psychiatry; 2013 Jan; 74(1):e87-93. PubMed ID: 23419235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence and Adherence to Psychostimulants, and Psychological Well-Being Up to 3 Years After Specialized Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Naturalistic Follow-Up Study.
    Bijlenga D; Kulcu S; van Gellecum T; Eryigit Z; Kooij JJS
    J Clin Psychopharmacol; 2017 Dec; 37(6):689-696. PubMed ID: 29049077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving psychostimulant adherence in children with ADHD.
    Charach A; Gajaria A
    Expert Rev Neurother; 2008 Oct; 8(10):1563-71. PubMed ID: 18928348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self concept, action control and ADHD symptoms under methylphenidate treatment in adults with ADHD.
    Edel MA; Pfütze EM; Lieder A; Assion HJ; Ribbert H; Juckel G; Brüne M
    Pharmacopsychiatry; 2009 May; 42(3):109-13. PubMed ID: 19452379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.
    Brams M; Giblin J; Gasior M; Gao J; Wigal T
    Postgrad Med; 2011 May; 123(3):99-108. PubMed ID: 21566420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of attention-deficit hyperactivity disorder on quality of life: case reports].
    Dallos G; Balázs J
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):91-7. PubMed ID: 24978052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention Deficit Hyperactivity Disorder Medication Use Among Teens and Young Adults.
    Johansen ME; Matic K; McAlearney AS
    J Adolesc Health; 2015 Aug; 57(2):192-7. PubMed ID: 26026476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.
    Zetterqvist J; Asherson P; Halldner L; Långström N; Larsson H
    Acta Psychiatr Scand; 2013 Jul; 128(1):70-7. PubMed ID: 22943458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
    Weiss MD; Gibbins C; Goodman DW; Hodgkins PS; Landgraf JM; Faraone SV
    J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence in psychopharmacologically treated adults with ADHD.
    Safren SA; Duran P; Yovel I; Perlman CA; Sprich S
    J Atten Disord; 2007 Feb; 10(3):257-60. PubMed ID: 17242421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder.
    Biederman J; Fried R; DiSalvo M; Woodworth KY; Biederman I; Noyes E; Faraone SV; Perlis RH
    J Clin Psychopharmacol; 2019; 39(4):351-356. PubMed ID: 31162154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.